Mannkind (MNKD) Return on Capital Employed Growth (3y) (2014 - 2026)
Mannkind (MNKD) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mannkind |
1.21 Bn |
1.08 Bn |
82.66 Mn |
2,508.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
2,508.00 |
| Dec 31, 2025 |
3,642.00 |
| Sep 30, 2025 |
5,392.00 |
| Jun 30, 2025 |
5,278.00 |
| Mar 31, 2025 |
5,109.00 |
| Dec 31, 2024 |
4,123.00 |
| Sep 30, 2024 |
3,807.00 |
| Jun 30, 2024 |
3,397.00 |
| Mar 31, 2024 |
4,165.00 |
| Dec 31, 2023 |
17,143.00 |
| Sep 30, 2023 |
-52,070.00 |
| Jun 30, 2023 |
13,651.00 |
| Mar 31, 2023 |
18,134.00 |
| Dec 31, 2022 |
12,656.00 |
| Sep 30, 2022 |
13,675.00 |
| Jun 30, 2022 |
34,276.00 |
| Mar 31, 2022 |
21,551.00 |
| Dec 31, 2021 |
591,988.00 |
| Sep 30, 2021 |
-168,802.00 |
| Jun 30, 2021 |
-83,166.00 |
